Drive Therapeutics
Cambridge, United States· Est. 2019
Biotechnology start-up based in RTP, NC. Drive Therapeutics has developed novel aptamer based therapies for wAMD, DME and other retinal diseases that will address efficacy and treatment intervals in these diseases.
Private Company
Total funding raised: $26.0M
About
Biotechnology start-up based in RTP, NC. Drive Therapeutics has developed novel aptamer based therapies for wAMD, DME and other retinal diseases that will address efficacy and treatment intervals in these diseases.
OphthalmologyGene Therapy
Funding History
9Total raised:$26.0M
Series A$15MJun 15, 2022
Seed$5MJun 15, 2022
Seed$5MJun 15, 2021
Grant$155KAug 10, 2017